USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2023-11-08 обновлены отчеты компании SUPN: 2023-Q32022-Q42022-Q3
Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
$ 30.83 1.85%

Supernus Pharmaceuticals Мультипликаторы 2011-2024 | SUPN

Мультипликаторы по годам Supernus Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

32.7 30.7 12.2 10.9 17.4 35.7 13.8 38.4 18.1 -3.4 -2.9 -

P/S

3.0 2.8 3.0 3.1 4.7 6.8 5.9 3.7 2.9 25.9 90.7 -

EPS

1.1 1.0 2.4 2.2 2.1 1.1 1.8 0.3 -0.3 -2.9 -2.7 31.4

EV (Enterprise Value)

2.71 млрд 2.31 млрд 2.02 млрд 1.61 млрд 2.26 млрд 2.1 млрд 1.31 млрд 575 млн 389 млн 356 млн 130 млн -4.26 млн

EBITDA per Share

2.45 2.23 3.65 2.96 2.91 2.12 1.14 0.391 0.595 -1.92 -2.37 -

EV/EBITDA

19.1 8.5 9.0 13.6 18.0 21.1 27.5 13.9 -5.1 -2.8 -

PEG

4.93 1.41 0.18 7.72 0.2 -0.92 0.03 -1.06 0.16 0.51 0.02 -

P/B

2.2 2.0 2.1 2.1 4.3 7.6 6.6 4.5 5.0 9.3 2.3 -

P/CF

17.0 12.9 11.2 8.8 15.1 18.1 19.3 17.9 50.3 -5.2 -2.8 -

ROE %

6.85 6.55 17.04 18.99 24.50 21.42 47.57 11.79 27.85 -275.74 -80.40 -

ROA %

3.57 3.16 8.44 9.74 11.35 13.50 29.47 7.43 14.45 -83.13 -49.24 -

ROCE %

5.20 10.54 23.32 14.86 17.69 33.02 23.69 13.32 22.02 -73.20 -59.39 -

Current Ratio

2.1 1.9 2.0 2.9 3.1 1.9 1.9 1.9 4.0 3.7 4.0 -

DSO

86.0 91.2 80.0 81.2 91.9 79.2 70.5 65.5 51.6 168.2 166.5 -

DIO

371.4 326.5 260.8 583.4 609.9 391.1 511.6 545.4 852.0 2364.6 - -

DPO

41.6 37.6 56.7 222.2 75.9 164.2 245.3 186.9 118.1 6054.9 - -

Операционный цикл

457.4 417.7 340.8 664.5 701.8 470.3 582.1 610.9 903.7 2532.7 - -

Финансовый цикл

415.8 380.1 284.1 442.4 625.8 306.1 336.8 424.0 785.6 -3522.2 - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Supernus Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.29 -0.02 0.31 - 0.03 0.15 0.48 - 0.41 0.45 0.11 - 0.76 0.66 0.41 0.63 0.55 0.62 0.35 0.5 0.54 0.59 0.51 0.27 0.31 0.34 0.21 0.29 1.25 0.21 0.1 0.14 0.08 0.05 0.02 0.09 -0.06 0.08 -0.38 -0.65 -0.78 -0.89 -0.6 -0.51 -0.55 -0.61 -6.05 2.88 -6.64 -5.17 -7.48

EBITDA per Share

0.16 -0.31 0.47 - -0.01 0.23 0.44 - 0.99 0.89 0.37 - 1.31 0.96 0.59 0.78 0.85 0.88 0.52 0.76 0.82 0.76 0.64 0.67 0.56 0.56 0.35 0.33 0.44 0.26 0.14 - 0.12 0.09 0.1 - - 0.1 -0.32 - -0.54 -0.49 -0.57 - -0.48 -0.52 -4.57 - -5.81 -5 -5.64

ROE %

0.22 2.18 3.20 4.23 6.89 9.35 11.43 6.44 11.81 14.51 16.15 12.91 18.48 17.95 18.80 18.99 19.14 20.48 21.76 24.50 23.89 23.68 23.38 21.42 23.78 50.05 48.91 47.57 47.89 20.10 17.52 15.84 17.36 7.09 8.81 -13.82 -90.08 -156.26 -242.49 -275.74 -232.25 -183.67 -119.31 -80.40 811.18 731.51 670.79 569.89 -103.08 -78.12 -117.01

ROA %

-0.26 1.09 1.62 2.13 3.52 4.80 5.84 3.27 5.93 7.20 8.00 6.39 9.25 9.08 9.59 9.74 9.54 9.91 10.24 11.35 11.92 12.82 13.76 13.50 14.90 31.12 30.33 29.47 28.47 10.58 8.56 7.39 6.53 2.72 3.76 -7.94 -30.89 -50.87 -77.85 -83.13 -77.32 -69.96 -55.96 -49.24 117.70 113.93 110.85 100.16 -18.12 -13.73 -20.56

ROCE %

-0.63 -1.70 1.56 1.41 5.43 9.63 12.63 10.12 17.65 21.17 22.94 17.55 24.40 23.54 24.58 24.95 26.89 28.49 29.23 31.88 35.93 36.01 37.87 37.21 32.87 34.87 31.19 28.27 25.55 20.99 19.28 14.73 12.92 5.33 6.23 -15.35 -66.68 -116.19 -167.71 -151.09 -172.44 -142.47 -112.29 -51.11 -156.11 -239.76 -312.59 -291.32 -105.00 -88.91 -97.41

Current Ratio

3.5 3.5 2.0 2.1 2.0 2.0 2.0 1.9 2.1 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 1.9 1.9 1.9 1.9 2.7 2.7 2.7 2.7 2.6 2.6 2.6 2.6 1.9 1.9 1.9 1.9 1.4 1.4 2.1 2.1 1.4 1.4 1.4 1.4 2.6 2.6 2.6 2.6 1.2 1.2 1.2 1.2

DSO

82.5 94.3 91.7 - 82.9 81.3 88.0 - 83.3 85.3 93.4 - 82.9 101.4 109.6 79.3 78.0 76.1 101.6 81.0 91.2 94.3 85.0 67.7 74.4 78.9 84.9 60.8 66.7 73.4 69.6 54.1 60.1 66.3 68.5 50.5 70.2 57.1 113.2 44.6 366.9 1641.2 1572.0 21.4 250.7 - 28.1 139.1 - - -

DIO

405.1 393.1 355.3 - 296.2 387.3 444.6 - 299.1 198.0 300.7 - 206.2 525.8 823.6 - 504.2 600.8 647.6 - 556.5 635.7 584.1 - 350.0 385.3 512.2 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

18.1 34.5 43.0 - 90.9 106.7 55.1 - 41.3 24.0 36.9 - 26.2 66.9 179.0 - 192.0 228.8 165.2 - 69.3 79.2 139.7 - 146.9 161.8 230.5 - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

487.6 487.4 447.0 - 379.1 468.6 532.6 - 382.3 283.3 394.1 - 289.0 627.3 933.3 79.3 582.2 677.0 749.1 81.0 647.7 730.1 669.1 67.7 424.4 464.2 597.1 60.8 66.7 73.4 69.6 54.1 60.1 66.3 68.5 50.5 70.2 57.1 113.2 44.6 366.9 1641.2 1572.0 21.4 250.7 - 28.1 139.1 - - -

Финансовый цикл

469.5 452.9 404.1 - 288.2 361.9 477.5 - 341.1 259.3 357.1 - 262.8 560.4 754.3 79.3 390.2 448.1 584.0 81.0 578.4 650.9 529.4 67.7 277.5 302.5 366.6 60.8 66.7 73.4 69.6 54.1 60.1 66.3 68.5 50.5 70.2 57.1 113.2 44.6 366.9 1641.2 1572.0 21.4 250.7 - 28.1 139.1 - - -

Все данные представлены в валюте USD